Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV Infection
Wei LiniD, Jue FaniD, Longfei Hu, Yan ZhangiD, Joshua Daniel OoiiD, Ting MengiD, Peng Jin, Xiang DingiD, Longkai PengiD, Lei SongiD, Rong Tang, Zhou Sheng Xiao, Xiang Ao, Xiangcheng XiaoiD, Qiaoling ZhouiD, Ping XiaoiD, Yong ZhongiD
Abstract
Since December 2019, a novel coronavirus named 2019 coronavirus (2019-nCoV) has emerged in Wuhan of China and spread to several countries worldwide within just one month. Apart from fever and respiratory complications, acute kidney injury has been observed in some patients with 2019-nCoV. In a short period of time, angiotensin converting enzyme II (ACE2), have been proposed to serve as the receptor for the entry of 2019-nCoV, which is the same for severe acute respiratory syndrome coronavirus (SARS). To investigate the possible cause of kidney damage in 2019-nCoV patients, we used both published kidney and bladder cell atlas data and an independent unpublished kidney single cell RNA-Seq data generated in-house to evaluate ACE2 gene expressions in all cell types in healthy kidneys and bladders. Our results showed the enriched expression of all subtypes of proximal tubule cells of kidney and low but detectable levels of expression in bladder epithelial cells. These results indicated the urinary system is a potential route for 2019-nCoV infection, along with the respiratory system and digestion system. Our findings suggested the kidney abnormalities of SARS and 2019-nCoV patients may be due to proximal tubule cells damage and subsequent systematic inflammatory response induced kidney injury. Beyond that, laboratory tests of viruses and related indicators in urine may be needed in some special patients of 2019-nCoV.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 77
- FWCI
- 3.24
- Field percentile
- top 6%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19
- RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells
Ayshwarya Subramanian, Katherine A. Vernon, … Anna Greka·bioRxiv·Jun 23, 2020
- Cell-Type-Specific Expression of Renin-Angiotensin-System Components in the Human Body and Its Relevance to SARS-CoV-2 Infection
Hemant Suryawanshi, Pavel S Morozov, … Thomas Tuschl·bioRxiv·Apr 11, 2020
- Kidney and Lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19
J. Wysocki, E. Lores, … D. Batlle·bioRxiv·May 20, 2020
- Increasing Host Cellular Receptor--Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV Infection
P.-H. Wang·bioRxiv·Feb 24, 2020
- Kidney injury molecule-1 is a potential receptor for SARS-CoV-2